Based in Cambridge, Massachusetts, ARIAD is dedicated to researching and developing drugs that target proteins and pathways involved in cancer. Their team is made up of diverse individuals who share a passion for transforming the lives of cancer patients. ARIAD's focus on oncology has led to their acquisition by Takeda Pharmaceuticals, a move that will allow them to continue their mission of developing innovative cancer treatments.